PeptideStack
5.2kquestions
20kanswers
220users

Is an ERP order from Hangzhou likely to hold cold chain to South Africa?

Asked 29 Apr 2024Modified 23 months agoViewed 25k times
2

The specifics, since they change the answer: ERP · Hangzhou · South Africa.

I would like to set this up properly once, rather than adjust it repeatedly.

My budget is real but not tight, and my tolerance for uncertainty is low.

What should I decide now, and what should I defer?

cold-chain
cold-chain

Keeping material within a temperature window from manufacture to use: phase-change packs versus dry ice, thermal mass, transit-lane temperature…

578 questions
international-shipping
international-shipping

Cross-border movement of research material: transit lanes and their thermal profiles, tracked versus untracked, declaration accuracy, and what…

471 questions
vendor-comparison
vendor-comparison

Side-by-side comparison of suppliers on measurable axes - independently confirmed purity and content, lead time, cold-chain handling,…

388 questions
shareeditfollowflag
CR
askedcoring_risk27k2729 Apr 2024

5 Answers

Accepted answer first, then by votes
74

Accepted answer

The relevant detail is that this is where the anxiety in this hobby is most out of proportion to the chemistry.

A single-use temperature logger costs a few pounds, records the whole journey and converts an argument into a record. If the history matters, this is the answer.

Mechanically, once the parcel arrives, the domestic leg is the controllable part: get it into the refrigerator promptly rather than leaving it in a warm hallway for a day.

Arrhenius kinetics predict approximately a doubling of degradation rate per ten-degree rise and are the standard basis for cold-chain design.

Solutions are a different question and deserve the worry the solids get.

shareimprove this answerflag
BD
answered · acceptedb_delacroix43k384 Jul 2024
Sponsored

Sigma-Aldrich - Certified Reference Materials

Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.

Shop standards
28

Put another way, the domestic leg after arrival is the part most often left in a warm hallway and least often worried about.

Anything shipped in solution is a different risk category, because hydrolysis and deamidation proceed in the aqueous phase and are strongly temperature-dependent.

Arrhenius behaviour means the degradation rate roughly doubles per ten degrees. A week at thirty degrees is therefore a meaningful exposure for a solution and an immaterial one for a dry solid.

Solid-state stability of lyophilised peptides at ambient temperature is documented in formulation studies with residual moisture as the dominant variable.

Reconstituted material has a genuine cold-chain requirement and it starts the moment water is added.

Buy a logger if you actually want to know. Everything else is inference.

edited 26 Jul 2024 by w_okoye — clarified the distinction between purity and content

shareimprove this answerflag
WO
answeredw_okoye43k13715 Jul 2024
Adding for future readers: the domestic leg after delivery is the part you control. – ayo_fadipe 3 months ago
add a comment
24

Start with the physical state, because it changes the answer completely and is the first thing to establish.

That is the argument for shipping lyophilised rather than for shipping colder. A dry powder with low residual moisture is stable at ambient for months; the pathways that matter need water.

Mechanically, asking a supplier to hold a shipment during a heatwave is reasonable and the better ones agree; the cost is a week and the benefit is a shorter warm exposure for anything in solution.

Single-use temperature loggers are standard practice in supply chains where temperature genuinely matters and are inexpensive at parcel scale.

The domestic leg is the part you control. Refrigerate it promptly.

shareimprove this answerflag
LT
answeredlane_transit60k4726 Jul 2024
8Does the same reasoning apply to material already in solution, or is that a different curve? – kirsi_lahtinen 1 months ago
7The desiccant point is under-appreciated and costs nothing to act on. – tri_gly_ala 10 months ago
add a comment
12

Answer first: for a lyophilised solid the cold chain matters far less than people believe, and for a solution it matters far more than they act as though it does.

A single phase-change pack in a thin-walled box holds below ten degrees for roughly one to two days at twenty-five degrees ambient, and under a day at thirty-five. On a nine-to-fourteen-day lane the material is at ambient for most of the journey whatever was packed with it.

Phase-change pack hold time is a function of mass, latent heat and insulation, and published figures for small parcels are on the order of one to two days.

The caveat is that a warm transit is survivable for a solid and materially different for a solution.

Lyophilised tolerates the lane. That is the answer for almost every order.

shareimprove this answerflag
FC
answeredforty_two_c66k5818 Aug 2024
-2

If temperature history matters to you, buy a data logger. It is the only way to know.

A pack that arrived hard tells you about the last day of transit only, since it will have melted and, if the ambient dropped, partially refrozen.

Deamidation kinetics for asparagine in peptides are well characterised and strongly sequence-dependent: the residue following the asparagine dominates the rate, with glycine and serine at the n+1 position accelerating it by an order of magnitude relative to bulkier residues. That is why two peptides in the same buffer at the same temperature can have quite different shelf lives.

Nothing here is medical advice, and research-use compounds are not approved for human use.

A liquefied pack is expected. It is not evidence of a problem.

shareimprove this answerflag
IB
answeredines_brandt113k2577 Aug 2024
3Aliquoting before the first freeze is the advice I wish I had read two years ago. – one_ml_bac 8 months ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.